Compliance with mismatch repair testing in pT1 colorectal cancer diagnosed before the age of 70 years

[1]  I. Nagtegaal,et al.  Evaluation of yield and experiences of age‐related molecular investigation for heritable and nonheritable causes of mismatch repair deficient colorectal cancer to identify Lynch syndrome , 2020, International journal of cancer.

[2]  I. Tomlinson,et al.  Guidelines for the management of hereditary colorectal cancer from the British Society of Gastroenterology (BSG)/Association of Coloproctology of Great Britain and Ireland (ACPGBI)/United Kingdom Cancer Genetics Group (UKCGG) , 2019, Gut.

[3]  A. Cavazza,et al.  Experience of the implementation and outcomes of universal testing for Lynch syndrome in the United Kingdom , 2019, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[4]  E. Dekker,et al.  Stage distribution of screen-detected colorectal cancers in the Netherlands , 2017, Gut.

[5]  J. Mecklin,et al.  Subtotal Colectomy for Colon Cancer Reduces the Need for Subsequent Surgery in Lynch Syndrome , 2017, Diseases of the colon and rectum.

[6]  R. Yantiss,et al.  Diagnostic Challenges Caused by Endoscopic Biopsy of Colonic Polyps: A Systematic Evaluation of Epithelial Misplacement With Review of Problematic Polyps From the Bowel Cancer Screening Program, United Kingdom , 2016, The American journal of surgical pathology.

[7]  E. Kuipers,et al.  Cost-effectiveness of routine screening for Lynch syndrome in colorectal cancer patients up to 70 years of age , 2016, Genetics in Medicine.

[8]  P. Møller,et al.  Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database , 2015, Gut.

[9]  Y. Niv,et al.  Immunohistochemistry staining for mismatch repair proteins: the endoscopic biopsy material provides useful and coherent results. , 2015, Human pathology.

[10]  Randall W Burt,et al.  ACG Clinical Guideline: Genetic Testing and Management of Hereditary Gastrointestinal Cancer Syndromes , 2015, The American Journal of Gastroenterology.

[11]  F. Lalloo,et al.  Colonoscopy screening compliance and outcomes in patients with Lynch syndrome , 2015, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[12]  P. Møller,et al.  Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts , 2013, Gut.

[13]  J. Potter,et al.  Identification of Lynch syndrome among patients with colorectal cancer. , 2012, JAMA.

[14]  E. Kuipers,et al.  Yield of routine molecular analyses in colorectal cancer patients ≤70 years to detect underlying Lynch syndrome , 2012, The Journal of pathology.

[15]  A. Bateman,et al.  DNA mismatch repair enzyme immunohistochemistry in colorectal cancer: a comparison of biopsy and resection material , 2010, Pathology.

[16]  M. Arends,et al.  DNA mismatch repair deficiency in sporadic colorectal cancer and Lynch syndrome , 2010, Histopathology.

[17]  E. Kuipers,et al.  A review on the molecular diagnostics of Lynch syndrome: a central role for the pathology laboratory , 2009, Journal of cellular and molecular medicine.

[18]  J. Habbema,et al.  Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy , 2009, Gut.

[19]  Heather Hampel,et al.  Feasibility of screening for Lynch syndrome among patients with colorectal cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  A. Verbeek,et al.  Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. , 2008, Gastroenterology.

[21]  M. Casparie,et al.  Pathology Databanking and Biobanking in The Netherlands, a Central Role for PALGA, the Nationwide Histopathology and Cytopathology Data Network and Archive , 2007, Cellular oncology : the official journal of the International Society for Cellular Oncology.

[22]  A. Cats,et al.  Decision analysis in the surgical treatment of colorectal cancer due to a mismatch repair gene defect , 2003, Gut.

[23]  D. Altieri.  Cytokinesis, apoptosis and survivin: Three for tango? , 2001, Cell Death and Differentiation.

[24]  L. Aaltonen,et al.  Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. , 2000, Gastroenterology.

[25]  H T Lynch,et al.  New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. , 1999, Gastroenterology.

[26]  Jeffrey R. Botkin,et al.  Summary of Recommendations: The Evaluation of Genomic Applications , 2022 .